scispace - formally typeset
W

W. K. Poole

Researcher at Brigham and Women's Hospital

Publications -  8
Citations -  3783

W. K. Poole is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & Digoxin. The author has an hindex of 7, co-authored 8 publications receiving 3593 citations.

Papers
More filters
Journal ArticleDOI

Circadian variation in the frequency of onset of acute myocardial infarction

TL;DR: If coronary arteries become vulnerable to occlusion when the intima covering an atherosclerotic plaque is disrupted, the circadian timing of myocardial infarction may result from a variation in the tendency to thrombosis.
Journal ArticleDOI

TIMI Frame Count A Quantitative Method of Assessing Coronary Artery Flow

TL;DR: The CTFC is a simple, reproducible, objective and quantitative index of coronary flow that allows standardization of TIMI flow grades and facilitates comparisons of angiographic end points between trials.
Journal ArticleDOI

Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study.

TL;DR: The findings in the MILIS population do not support the assertion that digoxin therapy is excessively hazardous after infarction, but the existence of an undetected harmful effect can only be excluded with a randomized study.
Journal ArticleDOI

Pericarditis in acute myocardial infarction: characterization and clinical significance.

TL;DR: To determine the significance of pericarditis following acute myocardial infarction, the hospital course and 12-month follow-up were analyzed in 703 patients enrolled in the Multicenter Investigation of the Limitation of Infarct Size (MILIS).
Journal ArticleDOI

Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course.

TL;DR: Data indicate that the beta-blockade withdrawal phenomenon is not a major clinical problem in patients with acute myocardial infarction and beta-Blockade therapy can be discontinued abruptly during acute my Cardiac Infarction if clinically indicated.